What AI says about KalVista

KalVista Pharmaceuticals is a biopharmaceutical company focused on developing orally delivered small molecule medicines for hereditary angioedema (HAE). The company aims to change the HAE treatment landscape by providing the first and only oral on-demand treatment option for patients.